154 related articles for article (PubMed ID: 19895176)
1. Relationship between plasma progesterone, estradiol and prolactin concentrations and breast cancer in pre and postmenopausal women.
Raheem SN; Atoum M; Al-Hourani H; Rasheed M; Nimer N; Almuhrib T
Neoplasma; 2010; 57(1):74-8. PubMed ID: 19895176
[TBL] [Abstract][Full Text] [Related]
2. A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer.
Olsson H; Borg A; Ewers SB; Fernö M; Möller T; Ranstam J
Med Oncol Tumor Pharmacother; 1986; 3(2):77-81. PubMed ID: 3747639
[TBL] [Abstract][Full Text] [Related]
3. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
4. Serum hormones in human breast cancer subjects.
Krishnamoorthy G; Govindarajulu P; Ramalingam V
Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392
[TBL] [Abstract][Full Text] [Related]
5. Peptide and steroid hormone levels in pre- and postmenopausal breast carcinoma.
Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
Neoplasma; 1987; 34(1):95-9. PubMed ID: 3104809
[TBL] [Abstract][Full Text] [Related]
6. Plasma hormones in pre- and postmenopausal breast cancer.
Drafta D; Schindler AE; Milcu SM; Keller E; Stroe E; Horodniceanu E; Bălănescu I
J Steroid Biochem; 1980 Jul; 13(7):793-802. PubMed ID: 6774172
[No Abstract] [Full Text] [Related]
7. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
[TBL] [Abstract][Full Text] [Related]
8. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
[TBL] [Abstract][Full Text] [Related]
9. [Mastopathy and breast cancer: is there a typical hormone profile?].
Völker W; Leipert KP; Gehrlings H; Stauch G; von zur Mühlen A; Schneider J
Geburtshilfe Frauenheilkd; 1986 May; 46(5):284-9. PubMed ID: 3087811
[TBL] [Abstract][Full Text] [Related]
10. Hormone concentrations in postmenopausal patients with breast cancer.
Jones MK; Ramsay ID; Booth M; Collins WP
Clin Oncol; 1977 Jun; 3(2):177-81. PubMed ID: 872471
[No Abstract] [Full Text] [Related]
11. Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels.
Saez S; Martin PM; Chouvet CD
Cancer Res; 1978 Oct; 38(10):3468-73. PubMed ID: 688231
[TBL] [Abstract][Full Text] [Related]
12. Endogenous sex hormones, prolactin, and breast cancer in premenopausal women.
Meyer F; Brown JB; Morrison AS; MacMahon B
J Natl Cancer Inst; 1986 Sep; 77(3):613-6. PubMed ID: 3462404
[TBL] [Abstract][Full Text] [Related]
13. Endocrine status in stage II vs. advanced premenopausal and postmenopausal breast cancer patients.
Bhatavdekar JM; Patel DD; Shah NG; Giri DD; Vora HH; Karelia NH; Trivedi SN; Ghosh N; Suthar TP
Neoplasma; 1992; 39(1):39-42. PubMed ID: 1388248
[TBL] [Abstract][Full Text] [Related]
14. Sex hormones in breast disease.
England PC; Skinner LG; Cottrell KM; Sellwood RA
Br J Surg; 1975 Oct; 62(10):806-9. PubMed ID: 1191940
[TBL] [Abstract][Full Text] [Related]
15. Estradiol and progesterone in human breast cancer cytosols and their relationship to receptor incidence.
Beattie CW; Briele HA; Hart G; Das Gupta TK
Cancer Invest; 1983; 1(3):199-206. PubMed ID: 6667405
[TBL] [Abstract][Full Text] [Related]
16. Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment.
Borkowski A; L'hermite M; Dor P; Longeval E; Rozencweig M; Muquardt C; Van Cauter E
J Endocrinol; 1977 May; 73(2):235-46. PubMed ID: 140915
[TBL] [Abstract][Full Text] [Related]
17. Abnormalities in evening plasma prolactin levels in nulliparous women with benign or malignant breast disease.
Tarquini A; di Martino L; Malloci A; Kwa HG; van der Gugten AA; Bulbrook RD; Wang DY
Int J Cancer; 1978 Dec; 22(6):687-90. PubMed ID: 721323
[TBL] [Abstract][Full Text] [Related]
18. Plasma lipids and prolactin in patients with breast cancer.
Bani IA; Williams CM; Boulter PS; Dickerson JW
Br J Cancer; 1986 Sep; 54(3):439-46. PubMed ID: 3756079
[TBL] [Abstract][Full Text] [Related]
19. [FSH, LH, prolactin, estradiol and progesterone after burn injuries in premenopausal and postmenopausal women].
Cepický P; Bucek S; Königová R; Stroufová A; Uzel R
Cesk Gynekol; 1990 Nov; 55(9):641-4. PubMed ID: 2093446
[TBL] [Abstract][Full Text] [Related]
20. Serum hormone levels in breast cancer patients and controls in Egypt and Great Britain. The Anglo-Egyptian Health Agreement Collaborative Study.
Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1329-35. PubMed ID: 3181253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
